The Importance of Thrombotic Risk Factors in the Development of Idiopathic Sudden Hearing Loss
Open Access
- 19 June 2008
- journal article
- Published by SAGE Publications in Clinical and Applied Thrombosis/Hemostasis
- Vol. 14 (3) , 356-359
Abstract
Impaired cochlear blood circulation has been suggested to cause sudden hearing loss. In this study, the role of factor V 1691 G-A (FV 1691 G-A), prothrombin 20210 G-A (PT 20210 G-A), methylene tetrahydrofolate reductase 677 C-T (MTHFR 677 C-T), factor V 4070 A-G (FV 4070 A-G), endothelial cell protein C receptor (EPCR) gene 23-bp insertion, and plasminogen activator inhibitor-1 (PAI-1) 4G/5G mutation was assessed. Fifty-three patients with idiopathic sudden sensorineural hearing loss and 80 individuals comprising the control group were included in this study. The frequency for FV 1691 A was 6.2% in the patient group and 3.7% in the control group, PT 20210 G-A was 1.2% in the patient group and 1.9% in the control group, and FV 4070 A-G was 7.5% in the patient group and 11.3% in the control group. The frequency of MTHFR 677 C-T was significantly higher in the patient group than in the control group, with a P value of .03. PAI-1-675 4G/5G polymorphism was found to be 71.2% and 69.8%, in the control group and the patient group, respectively. The EPCR 23-bp insertion was 0% in the control group and was found in 3 patients (3.7%), which needs further study.Keywords
This publication has 21 references indexed in Scilit:
- The Role of Factor V Leiden and Prothrombin G20210a Mutations in Sudden Sensorineural Hearing LossOtology & Neurotology, 2005
- Haplotypes of the EPCR gene, plasma sEPCR levels and the risk of deep venous thrombosisJournal of Thrombosis and Haemostasis, 2004
- Crosstalk between inflammation and thrombosisMaturitas, 2004
- A haplotype of the EPCR gene is associated with increased plasma levels of sEPCR and is a candidate risk factor for thrombosisBlood, 2004
- The Protein C PathwayChest, 2003
- Effect of Plasminogen Activator Inhibitor-1 4G/5G Polymorphism in Turkish Deep Vein Thrombotic Patients with and without FV1691 G-AThrombosis Research, 2000
- Effect Of Metylenetetrahydrofolate Reductase 677 C-T, 1298 A-C, and 1317 T-C on Factor V 1691 Mutation in Turkish Deep Vein Thrombosis PatientsThrombosis Research, 2000
- Hyperhomocysteinemia as a Risk Factor for Deep-Vein ThrombosisNew England Journal of Medicine, 1996
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- Natural History of Sudden Sensorineural Hearing LossAnnals of Otology, Rhinology & Laryngology, 1977